Brief: Biora Therapeutics Completed Agreement With Diagnostics Company For Sale Of Legacy Assets Related To Biora's Former Diagnostics Business
July 5 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS - COMPLETED AGREEMENT WITH A LARGE
DIAGNOSTICS COMPANY FOR SALE OF LEGACY ASSETS RELATED TO BIORA'S
FORMER DIAGNOSTICS BUSINESS
* BIORA THERAPEUTICS INC - WILL RECEIVE A ONE-TIME PAYMENT
FOR
SALE OF ASSETS INCLUDING RIGHTS TO CERTAIN ANTIBODY SEQUENCES
* BIORA THERAPEUTICS INC - SPECIFIC TERMS OF AGREEMENT WERE
NOT
DISCLOSED
Source text for Eikon: ID:nGNX9DNk8s
Further company coverage: BIOR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules